Colin J, Robinet A
Hospital Morvan, Centre Hospitalier Universitaire de Brest, France.
Ophthalmology. 1994 Jan;101(1):107-12. doi: 10.1016/s0161-6420(94)31379-0.
Although a variety of surgical procedures to treat high myopia have been studied, no consensus exists on the optimum procedure. Clear lensectomy with implantation of a posterior chamber intraocular lens has been regarded as risky, due to the higher incidence of retinal detachment in highly myopic eyes.
The authors performed surgery and evaluation over 1 year in 52 eyes in which prophylactic retinal treatment, clear lensectomy, and posterior chamber intraocular lens implantation were used to treat high myopia of 12 diopters (D) or greater.
Before lens extraction, 31 eyes underwent argon laser photocoagulation. Over the 1-year period, three additional eyes were treated, and six eyes that had been treated preoperatively received additional treatment. No cystoid macular edema, retinal detachment, or persistent corneal edema was observed in this series. At 1 year, 88.5% of the group achieved corrected visual acuity of 20/40 or better, compared with 75% preoperatively. Uncorrected visual acuity of 20/100 or better was achieved by 84.6% of the group. The mean postoperative spherical equivalent was -0.86 +/- 0.84 D.
The refractive objectives were achieved. Complications reported previously with clear lensectomy were not experienced in this group. The low incidence of complications can be attributed to the short follow-up and probably in part to the prophylactic retinal treatment, combined with the phacoemulsification procedure for lens extraction. Longer follow-up is needed to fully assess the complications. Properly randomized prospective clinical trials will be able to fully assess the benefits and risks of prophylactic retinal treatment and clear lens extraction with posterior intraocular lens implantation. This series can help in evaluating this surgical procedure.
尽管已经研究了多种治疗高度近视的外科手术方法,但对于最佳手术方法尚未达成共识。由于高度近视眼视网膜脱离的发生率较高,因此植入后房型人工晶状体的透明晶状体摘除术被认为具有风险。
作者对52只眼睛进行了为期1年的手术和评估,这些眼睛采用预防性视网膜治疗、透明晶状体摘除术和后房型人工晶状体植入术来治疗12屈光度(D)或更高的高度近视。
在晶状体摘除术前,31只眼睛接受了氩激光光凝治疗。在这1年期间,又有3只眼睛接受了治疗,6只术前接受过治疗的眼睛接受了额外治疗。该系列中未观察到黄斑囊样水肿、视网膜脱离或持续性角膜水肿。1年后,该组88.5%的患者矫正视力达到20/40或更好,而术前为75%。该组84.6% 的患者未矫正视力达到20/100或更好。术后平均等效球镜度为-0.86±0.84D。
达到了屈光目标。该组未出现先前报道的透明晶状体摘除术的并发症。并发症发生率低可归因于随访时间短,可能部分归因于预防性视网膜治疗,以及联合超声乳化晶状体摘除术。需要更长时间的随访来全面评估并发症。适当的随机前瞻性临床试验将能够全面评估预防性视网膜治疗以及透明晶状体摘除联合后房型人工晶状体植入的益处和风险。本系列研究有助于评估这种手术方法。